Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib

Por Gandhi MD, Agulnik M
Publicado em 2014-02-01

State-of-the-art management of nasopharyngeal carcinoma: current and future directions

Por Agulnik, M, Siu, L L
Publicado em 2005

WHOLE-FIELD SEQUENTIAL INTENSITY–MODULATED RADIOTHERAPY FOR LOCAL-REGIONAL ADVANCED HEAD-AND-NECK SQUAMOUS CELL CARCINOMA

Por Refaat, T., Choi, M., Thomas, T. O., Bacchus, I., Agulnik, M., Pelzer, H. J., Mellott, A. L., Rademaker, A. W., Liu, D., Sathiaseelan, V., Mittal, B.B.
Publicado no Am J Clin Oncol (2015)

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma(†)

Por Dickson, M. A., Mahoney, M. R., Tap, W. D., D'Angelo, S. P., Keohan, M. L., Van Tine, B. A., Agulnik, M., Horvath, L. E., Nair, J. S., Schwartz, G. K.
Publicado no Ann Oncol (2016)